Bielby Robert, Jones Elena, McGonagle Dennis
Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, UK.
Injury. 2007 Mar;38 Suppl 1:S26-32. doi: 10.1016/j.injury.2007.02.007.
The maintenance of stable bone mass during adult life, following rapid skeletal growth during childhood, is the result of a carefully controlled balance between the activities of bone forming (osteoblast) and bone resorbing (osteoclast) cells. Although skeletal turnover continues throughout adult life, the net effect of formation and resorption on bone mass is zero in healthy individuals. Later in life, bone mass begins to fall as resorption outpaces formation, particularly in post-menopausal women, which leads to increased fracture risk. The opposing actions of these two cell types are coupled by molecular interactions between them that are thought to be influenced by the actions of the precursor cells of the osteoblast lineage, mesenchymal stem cells (MSCs). In addition to regulating normal skeletal homeostasis, MSCs also play an important role in fracture repair. Bone fracture or injury initiates a series of cellular and molecular pathways that commence with hematoma formation and an inflammatory cascade that regulates MSCs activity leading to fracture healing and the reestablishment of skeletal integrity. Although tremendous strides have been made in increasing our understanding of bone biology, there is surprisingly little data about the role of MSCs in vivo in the maintenance of skeletal integrity or fracture repair. In recent years, the pivotal importance of anabolic therapies in the setting of osteoporosis in which bone mass is substantially increased above and beyond what is attainable with the bisphosphonate class of drugs has put MSC biology firmly on the scientific agenda. Although the biology of cultured MSCs is reasonably well understood, the biology of MSCs in vivo in both bone turnover and fracture repair remains poorly understood. The recent phenotypic characterization of in vivo MSCs and the ability to prospectively purify such cells will open up new avenues of research into a better understanding of the role of MSCs in bone turnover. The purpose of this article is to review bone and fracture biology from the perspective of recent advances in our understanding of MSCs and to highlight the major deficiencies in our current knowledge.
在童年期骨骼快速生长之后,成年期稳定骨量的维持是成骨细胞(造骨细胞)和破骨细胞的活动之间精确控制的平衡的结果。虽然骨骼更新在整个成年期持续进行,但在健康个体中,形成和吸收对骨量的净效应为零。在生命后期,随着吸收超过形成,骨量开始下降,尤其是在绝经后女性中,这导致骨折风险增加。这两种细胞类型的相反作用通过它们之间的分子相互作用而耦合,这种相互作用被认为受成骨细胞谱系的前体细胞——间充质干细胞(MSCs)的作用影响。除了调节正常的骨骼稳态外,间充质干细胞在骨折修复中也起重要作用。骨折或损伤引发一系列细胞和分子途径,始于血肿形成和调节间充质干细胞活性的炎症级联反应,从而导致骨折愈合和骨骼完整性的重建。尽管在增进我们对骨生物学的理解方面已经取得了巨大进展,但令人惊讶的是,关于间充质干细胞在体内维持骨骼完整性或骨折修复中的作用的数据很少。近年来,在骨质疏松症背景下,合成代谢疗法的关键重要性——其可使骨量大幅增加,超过双膦酸盐类药物所能达到的水平——已将间充质干细胞生物学牢固地置于科学议程之上。尽管对培养的间充质干细胞的生物学已有相当深入的了解,但间充质干细胞在体内骨转换和骨折修复中的生物学仍知之甚少。最近对体内间充质干细胞的表型特征描述以及前瞻性纯化此类细胞的能力,将为更好地理解间充质干细胞在骨转换中的作用开辟新的研究途径。本文的目的是从我们对间充质干细胞理解的最新进展的角度回顾骨和骨折生物学,并突出我们当前知识中的主要不足。
Injury. 2011-4-13
Injury. 2005-12
Injury. 2005-11
Anat Rec (Hoboken). 2010-3
Exploration (Beijing). 2025-2-27
Front Med (Lausanne). 2024-8-29
Bioengineering (Basel). 2024-1-31
Int J Mol Sci. 2023-7-24
BMC Musculoskelet Disord. 2023-1-20